Therapeutic Asset Ratings

165 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
tj0113 Parkinson Disease	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CCC (51)
Egfr/B7H3 Car-T Glioblastoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1/2	CCC (50)
Atirizumab Hepatocellular Carcinoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CCC (48)
Dual Antibody B Glioblastoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CCC (48)
ibi351 Colorectal Cancer Metastatic	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CCC (48)
Supplementation Of ͢-Sitosterol Subarachnoid Hemorrhage	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1/2	CCC (48)
Bemalenograstim Alfa Colorectal Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CC (46)
Bemalenograstim Alfa Pancreatic Neoplasm	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CC (46)
Ckd-581 Breast Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CC (46)
Recombinant Mutant Human Tumor Necrosis Factor Colorectal Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P2	CC (46)
Cea-Targeted Car-T Breast Cancer	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1/2	CC (45)
Anti-Cd19 Car-Nk Cells Primary Central Nervous System Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Anti-Cd19 Il10/Il15 Car-Nk B-Cell Non-Hodgkin Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Anti-Lilra6 Car-T Cells Acute Myeloid Leukemia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Car-Dc Idiopathic Pulmonary Fibrosis	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Car-Nk-Cd19 Cells Diffuse Large B-Cell Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Car-Nk-Cd19 Cells Primary Mediastinal Large B-Cell Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
CD19-CAR-DNT cells B-Cell Non-Hodgkin Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
cd19-car novel oncolytic vaccinia virus B-Cell Non-Hodgkin Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
cd70 car-nk Acute Myeloid Leukemia	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
cd70 car-nk T-Cell Non-Hodgkin Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Cea-Targeted Car-T Peritoneal Carcinomatosis	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Claudin18.2-Targeted Car-Dcs Colorectal Neoplasm	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Claudin18.2-Targeted Car-T Cells Colorectal Neoplasm	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)
Epc-003 Fully Human Anti-B7H3/Il13Ra2 Armored Car-T Cell Therapy Glioblastoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (43)

Showing 101 to 125 of 165 assets

PreviousPage 5 of 7Next